   |
|   |

| |
|
Funders
International Partners*
 |
Advanced Biosciences Laboratory, USA |
 |
AIDES, France |
 |
AIDS-Fondet, Denmark |
 |
Alliance for Microbicide Development, USA |
 |
Analytical Solutions, USA |
 |
BePart Community Research Solutions; Drakenstein Hospice, South Africa |
 |
Bristol-Myers Squibb, USA |
 |
CBR Institute for Biomedical Research |
 |
Centers for Disease Control and Prevention, USA |
 |
Clinical Research Centres SA, South Africa |
 |
Clinton Global Initiative, USA |
 |
CONRAD, USA |
 |
Cornell University, USA |
 |
Deseret International Foundation, Namibia |
 |
Desmond Tutu HIV Foundation, South Africa |
 |
Equilibres & Populations, France |
 |
European Microbicide Project, United Kingdom |
 |
Family Health International, USA |
 |
German Foundation for World Population (DSW), Germany |
 |
Gilead Sciences, Inc., USA |
 |
Global Campaign for Microbicides, USA |
 |
Harvard School of Public Health, USA |
 |
Health and Development Africa, South Africa |
 |
Imquest Biosciences, USA |
 |
Innovative Biotech, Ltd., Nigeria |
 |
Institute of Tropical Medicine, Belgium |
 |
Instituto Nacional de Saude (Mozambican National Institute of Health), Mozambique |
 |
Interagency Coalition on AIDS and Development, Canada |
 |
International Antiviral Therapy Evaluation Center, The Netherlands |
 |
International Centre for Reproductive Health, Kenya |
 |
Johns Hopkins University, USA |
 |
J-Star Research, USA |
 |
Kenya Medical Research Institute, Kenya |
 |
Kilimanjaro Reproductive Health Programme, Tanzania |
 |
Locus Pharmaceuticals, USA |
 |
London School of Hygiene and Tropical Medicine, United Kingdom |
 |
Madibeng Centre for Research, South Africa |
 |
McGill University, Canada |
 |
Medical Research Council, South Africa |
 |
Medical Research Council, Uganda |
 |
Merck & Co., Inc., USA |
 |
Microbicide Development Programme, United Kingdom |
 |
Mintaka Foundation, Switzerland |
 |
Mount Sinai School of Medicine, USA |
 |
National AIDS Trust, United Kingdom |
 |
National Institute for Research in Reproductive Health, India |
 |
National Institute of Allergy and Infectious Diseases, USA |
 |
Novovax, USA |
 |
Paragon Medsystems, USA |
 |
Particle Sciences, USA |
 |
Population Council, USA |
 |
Projet Ubuzima, Rwanda |
 |
Queen’s University of Belfast, United Kingdom |
 |
Regulatory Compliance Initiatives, USA |
 |
Research IQ, South Africa |
 |
Research Triangle Institute, USA |
 |
ScinoPharm, Taiwan |
 |
SGS Life Science Services, Belgium |
 |
Society for Women and AIDS in Africa, Namibia |
 |
Statistics Collaborative, USA |
 |
St. George’s, University of London, United Kingdom |
 |
Tibotec Pharmaceuticals, Ltd. (a subsidiary of Johnson & Johnson), Belgium |
 |
UNAIDS’ Global Coalition on Women and AIDS, Switzerland |
 |
University of Auckland, New Zealand |
 |
University of California, Los Angeles, USA |
 |
University of Ghent, Belgium |
 |
University of the Free State, South Africa |
 |
University of the Witwatersrand, Reproductive Health and HIV Research Unit, South Africa |
 |
University of Utah, USA |
 |
University of Zimbabwe, Zimbabwe |
 |
Urban Research and Development Centre for Africa, Kenya |
 |
Voxiva, USA |
 |
Warner Chilcott, United Kingdom |
 |
World Health Organization, Switzerland |
 |
Xigo Nanotools, USA |
*The above is a 2006 list of organizations working in partnership with IPM to advance its mission. |
|
|
| |
Worldwide headquarters: 8401 Colesville Road • Suite 200 • Silver Spring, MD 20910
(p) +1 301-608-2221 • (f) +1 301-608-2241
© Copyright 2008, International Partnership for Microbicides |
|
|   |